🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today we are releasing Gen-4 References to all paid plans. Now anyone can generate consistent characters, locations and more. With References, you can use photos, generated images, 3D models or selfies to place yourself or others into any scene you can imagine. More examples

(NEW POST) When The Iron Turns To Silk > how the world has shaped millennial & zoomer investing behavior > does US-China today resemble any historical parallels > nothing ever happens? link to full piece below

Thanks to everyone who joined online and in person for the fantastic talk by Jamie Shotton from Wayve!

Last year, Compound and USV co-hosted a Research Day on Biohacking. We thought the event was a culmination of our exploration of the field, but it opened our eyes to larger healthcare changes underway, with more company building than expected. We want to continue to

Compound USV forms.gle/a5wxt3Pd6vVEpT…

In the fall, we hosted an incredible Biohacker Research Day with our friends at Compound. Since then, we've felt the field accelerating. We've been amazed by the talent coming in and the truly mind-blowing things people are working on In that spirit, we were inspired to

This update brings a completely new set of creative capabilities and improvements to References. An interesting emergent property is the ability of the model to precisely place objects in your scene using a layout you can provide. If you find new use cases, please share them.

Releasing INTELLECT-2: We’re open-sourcing the first 32B parameter model trained via globally distributed reinforcement learning: • Detailed Technical Report • INTELLECT-2 model checkpoint primeintellect.ai/blog/intellect…

you can just train a 32B parameter model with globally distributed reinforcement learning loooots of very cool technical details + learnings in the thread and paper, both for decentralized async RL and for scaling up GRPO more broadly :)

(New Post) - The First 40 Months We've conditioned companies to sprint from round to round as they build their companies. In a world of haves and have nots, rapid ARR growth in AI, and large funds built on momentum, it may be more important than ever to know how to cross the

Read the full post here and subscribe for more writing: mhdempsey.substack.com/p/the-first-40…

"VCs are getting more and more antsy to back research projects." - Michael Dempsey, managing partner of Compound "For us (investing in deep tech), we're willing to underwrite founders taking a small technical breakthrough and scaling it, spinning out R&D labs, etc." "There are

(New Post) Narc Claude & The Mid-Stage of the AI Lab Cycle I wrote up a few quick thoughts on Claude Opus 4, AI Lab marketing strategies, and what they signal about the current stage of AI development cycle.

Saw Jure present on Biomni last month at Compound's Autonomous Science summit. Feels like a Cursor moment for scientists is shaping up. At Bio Protocol we are building on open-source agents and adding onchain elements. A large design space opens up when the agent has: +

(New Post) Risk Tokens: Economic Security in AI Safety There is a lot of interesting research these days surrounding understanding the internals of models as well as other areas of alignment + safety. With some of our work Compound Compound Researcher in biosecurity as well as

The full essay with footnotes can be read here: michaeldempsey.me/blog/2025/06/0…

Packed house at USV for the "Building AI Solutions in Health & Bio" event with 2048 Ventures 🧬 🤖 ⚙️, Compound and Zetta Ventures #NYTechWeek

We've got a new pod out now with Michael Dempsey of Compound 🎙️ 🤖 Agentic Disruption Comes For Big Tech 🚗 The Future of Robotaxis 🔍 Who Will Develop The "Killer App" of AI Watch or listen here ⤵️ YouTube: youtu.be/U65SZGRCgBU Apple: apple.co/4kMxzT1 Spotify:

"There's a world in which a decade plus ago... Steve Jobs gets on stage and says we will have AI when it's going to change your life and until then don't ask us about it." - Michael Dempsey of Compound talks $AAPL, AI & Autonomy on the latest podcast🎙️

Is making drugs for toxins and poisons a silly idea? Maybe not totally....as drug discovery commoditizes with better computational tools and faster feedback loops, there could be a world where the long-tail of diseases and events (like poisons and stings) could have much more